Cargando…
Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition()
Glycolysis is essential to Trypanosoma brucei, the causative agent of African sleeping sickness, suggesting enzymes in the pathway could be targets for drug development. Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one, EbSe) was identified in a screen as a potent inhibitor of T. brucei hexokinase 1...
Autores principales: | Joice, April C., Harris, Michael T., Kahney, Elizabeth W., Dodson, Heidi C., Maselli, Andrew G., Whitehead, Daniel C., Morris, James C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862409/ https://www.ncbi.nlm.nih.gov/pubmed/24533305 http://dx.doi.org/10.1016/j.ijpddr.2013.08.002 |
Ejemplares similares
-
A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2010) -
Comparative Analysis of the Interaction of Silver Nanoparticles with Hexokinase from Trypanosoma brucei and Humans
por: Mlozen, Madalitso M, et al.
Publicado: (2023) -
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei
por: Roster, Colm P., et al.
Publicado: (2023) -
Optimized Ebselen-Based
Inhibitors of Bacterial Ureases
with Nontypical Mode of Action
por: Macegoniuk, Katarzyna, et al.
Publicado: (2023) -
Modes of flagellar assembly in Chlamydomonas reinhardtii and Trypanosoma brucei
por: Höög, Johanna L, et al.
Publicado: (2014)